Viewed: 1322
Emailed: 0
PDF Downloaded: 1301
Full Text PDF Share on Facebook Share on Twitter
Original Article
Author Details :
Volume : 1, Issue : 2, Year : 2018
Article Page : 18-21
Abstract
Introduction: Dermatological changes are frequently seen in patients with chronic kidney disease (CKD). Aim of this study was to evaluate the frequency and pattern of hair, nail and cutaneous problems and number of patients with cutaneous manifestations and complications at the site of A-V fistula among CKD patients.
Material and Methods: It was a cross-sectional, observational study conducted in dermatology and nephrology departments at government medical college Kota, Rajasthan between June 2017 and December 2017. Patients with CKD were examined for the diagnosis of dermatological manifestations. An experienced dermatologist confirmed the diagnosis and histopathological examination was performed for doubtful cases. Disease characteristics like primary disease causing CKD, duration of CKD, stage of CKD, personal/ family history of structural kidney defects, and duration of hemodialysis were recorded.
Results: A total of 100 patients were included in the study. One or more muco-cutaneous manifestations were seen in 94(94%) patients. Xerosis was the most common skin manifestation observed in 70(70%) patients. The most common nail manifestation was leukonychia, seen in 22(22%) patients. The most common mucosal manifestations were ulcerative mucositis, observed in 22( 22%) patients. The most frequently observed hair manifestation dry and lustureless hairs seen in 26(26%). Local cutaneous changes at the site of A-V fistula were observed in 57(57%) patients.
Conclusion: In the present study, muco-cutaneous manifestations were common in CKD with E-GFR <15>
Keywords: Chronic kidney disease, Muco-cutaneous manifestation, E-GFR(estimated glomerular filtration rate), Hemodialysis, Xerosis.
How to cite : Agarwal S , Khandelia V , Agarwal V , Kumar A , Nama U , Frequency and pattern of muco-cutaneous manifestations in patients with chronic kidney disease on hemodialysis. J Urol Nephrol Hepatol Sci 2018;1(2):18-21
Copyright © 2018 by author(s) and J Urol Nephrol Hepatol Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)